Patents/Inventors

Muthiah Manoharan

Weston, MAUS33 patents

36 Patents

US125903052026
Complement Component C5 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US124976132025
Modified Oligonucleotides
Alnylam Pharmaceuticals, Inc.
0 cites
US124602062025
PCSK9 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US124537762025
Lipids and Compositions for the Delivery of Therapeutics
ARBUTUS BIOPHARMA CORPORATION
0 cites
US123970132025
Extrahepatic Delivery
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123850432025
Modified Double-stranded RNA Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123850442025
Modified Double-stranded RNA Agents
Alnylam Pharmaceuticals, Inc.
0 cites
US123785532025
Modified Double-stranded RNA Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123647622025
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123503382025
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US123433982025
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US122905732025
Modified Rnai Agents
Alnylam Pharmaceuticals, Inc.
0 cites
US122759382025
Modified RNA Agents with Reduced Off-target Effect
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US122472032025
Modified RNA Agents with Reduced Off-target Effect
Alnylam Pharmaceuticals, Inc.
0 cites
US122397092025
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US122410642025
REVERSIR™ Compounds
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US122216072025
Multi-targeted Single Entity Conjugates
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US121732872024
Compositions and Methods for Improving Strand Biased
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US121732882024
Oligonucleotide-ligand Conjugates and Process for Their Preparation
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US121687672024
Modified Double-stranded RNA Agents
Alnylam Pharmaceuticals, Inc.
0 cites
US120716192024
SERPINA1 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US120594682024
Carbohydrate Conjugates as Delivery Agents for Oligonucleotides
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US120425412024
Lipids and Compositions for the Delivery of Therapeutics
ARBUTUS BIOPHARMA CORPORATION
0 cites
US120233832024
Lipid Compositions
ARBUTUS BIOPHARMA CORPORATION
0 cites
US120050742024
Extrahepatic Delivery
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US119446872024
Carbohydrate Conjugate RNA Agents and Process for Their Preparation
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US118734912024
Complement Component C5 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US117252072023
Serpina1 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites
US116791582023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116666532023
Carbohydrate Conjugates as Delivery Agents for Oligonucleotides
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116334792023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116334802023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US116126572023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US115979322023
Chirally-enriched Double-stranded RNA Agents
Alnylam Pharmaceuticals, Inc.
0 cites
US115902292023
Biodegradable Lipids for the Delivery of Active Agents
ALNYLAM PHARMACEUTICALS, Inc.
0 cites
US115491092023
Modified Double-stranded RNA Agents
Alnylam Pharmaceuticals, Inc.
0 cites